A detailed history of Janus Henderson Group PLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,818,012 shares of BBIO stock, worth $113 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,818,012
Previous 4,312,531 11.72%
Holding current value
$113 Million
Previous $109 Million 12.29%
% of portfolio
0.07%
Previous 0.06%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.91 - $31.3 $12.1 Million - $15.8 Million
505,481 Added 11.72%
4,818,012 $123 Million
Q2 2024

Aug 14, 2024

BUY
$23.0 - $31.04 $23 Million - $31 Million
999,825 Added 30.18%
4,312,531 $109 Million
Q1 2024

May 15, 2024

BUY
$27.35 - $40.45 $59.3 Million - $87.7 Million
2,169,143 Added 189.68%
3,312,706 $102 Million
Q4 2023

Feb 14, 2024

SELL
$24.02 - $43.89 $1,201 - $2,194
-50 Reduced -0.0%
1,143,563 $46.2 Million
Q3 2023

Nov 14, 2023

BUY
$16.89 - $35.01 $18.6 Million - $38.5 Million
1,100,120 Added 2529.42%
1,143,613 $30.2 Million
Q2 2023

Aug 14, 2023

SELL
$13.29 - $18.01 $810,357 - $1.1 Million
-60,975 Reduced 58.37%
43,493 $748,000
Q1 2023

May 15, 2023

BUY
$7.17 - $18.55 $649,888 - $1.68 Million
90,640 Added 655.48%
104,468 $1.73 Million
Q4 2022

Feb 14, 2023

SELL
$6.74 - $11.52 $6 - $11
-1 Reduced 0.01%
13,828 $105,000
Q3 2022

Nov 14, 2022

SELL
$7.94 - $12.36 $1,881 - $2,929
-237 Reduced 1.68%
13,829 $137,000
Q2 2022

Aug 15, 2022

BUY
$5.21 - $12.14 $1,135 - $2,646
218 Added 1.57%
14,066 $128,000
Q1 2022

May 16, 2022

SELL
$7.34 - $17.16 $102 - $240
-14 Reduced 0.1%
13,848 $141,000
Q4 2021

Feb 14, 2022

SELL
$11.38 - $53.41 $29.9 Million - $141 Million
-2,631,579 Reduced 99.48%
13,862 $231,000
Q3 2021

Nov 16, 2021

SELL
$46.87 - $64.24 $7.74 Million - $10.6 Million
-165,211 Reduced 5.88%
2,645,441 $124 Million
Q2 2021

Aug 16, 2021

SELL
$46.47 - $63.93 $2.91 Million - $4 Million
-62,531 Reduced 2.18%
2,810,652 $171 Million
Q1 2021

May 17, 2021

BUY
$55.47 - $72.35 $60.4 Million - $78.8 Million
1,089,648 Added 61.09%
2,873,183 $177 Million
Q4 2020

Feb 16, 2021

BUY
$38.38 - $71.11 $3.53 Million - $6.55 Million
92,074 Added 5.44%
1,783,535 $127 Million
Q3 2020

Nov 16, 2020

SELL
$27.2 - $42.19 $2.02 Million - $3.14 Million
-74,403 Reduced 4.21%
1,691,461 $63.5 Million
Q2 2020

Aug 14, 2020

SELL
$22.22 - $35.69 $448,288 - $720,045
-20,175 Reduced 1.13%
1,765,864 $57.6 Million
Q1 2020

May 14, 2020

SELL
$16.11 - $36.23 $21.8 Million - $49.1 Million
-1,355,042 Reduced 43.14%
1,786,039 $51.8 Million
Q4 2019

Feb 18, 2020

BUY
$17.96 - $46.63 $48.3 Million - $125 Million
2,688,910 Added 594.67%
3,141,081 $110 Million
Q3 2019

Nov 14, 2019

BUY
$20.13 - $32.38 $2.14 Million - $3.44 Million
106,182 Added 30.69%
452,171 $9.71 Million
Q2 2019

Jul 31, 2019

BUY
$26.97 - $27.55 $9.33 Million - $9.53 Million
345,989 New
345,989 $9.33 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.47B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.